ASA Submits Recommendations to FDA for International Rescheduling of Cannabis
Americans for Safe Access
APRIL 23, 2018
In early April, the Food and Drug Administration (FDA) issued a notice in the federal register asking for public comments on cannabis and its derivatives. This week, we submitted comments relating to the efficacy and medical usefulness of cannabis as a medical treatment.
129 
Let's personalize your content